Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17627)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2021 (publication date) through Jul 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087 [PMID: 34326612 DOI: 10.3748/wjg.v27.i26.4045] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v27/i26/4045.htm |
| Number | Citing Articles |
| 1 |
FERRAN CORDÓN GRANADOS, MERITXELL SAURA PARRAMON. Cáncer de páncreas. Actualización en Medicina de Familia 2024; : 206 doi: 10.55783/AMF.200404
|
| 2 |
Maria Giulia Demarzo, Chiara Facchini, Giuliana Rosa Bisso, Ciro Marrone, Maria Caterina Parodi. Traditional Biomarkers in Patients with Pancreatic Cancer Staged by Computed Tomography and Endoscopic Ultrasound: Is There Still a Role in the Molecular Era?. Gastrointestinal Disorders 2024; 6(3): 733 doi: 10.3390/gidisord6030049
|
| 3 |
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, Sofía Madeline Osorio-Pérez, Hania Ruth Zlotnik-Chávez, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Translational Oncology 2023; 27: 101579 doi: 10.1016/j.tranon.2022.101579
|
| 4 |
Lizeth Ruiz‑Barrios, Tomás Pineda‑Razo, Georgina Hernández‑Flores, Pablo Ortiz‑Lazareno, Alejandro Bravo‑Cuéllar, Adriana Macias‑Lamas, Karina Parra‑Saavedra, Luis Palafox‑Mariscal, Adriana Aguilar‑Lemarroy, Luis Jave‑Suárez, María Villaseñor‑garcía. Expression of ornithine decarboxylase in peripheral blood mononuclear cells from patients with pancreatic adenocarcinoma: A preliminary report. Biomedical Reports 2024; 20(3) doi: 10.3892/br.2024.1726
|
| 5 |
Francesca Tavano, Anna Latiano, Orazio Palmieri, Domenica Gioffreda, Tiziana Latiano, Annamaria Gentile, Matteo Tardio, Tiziana Pia Latiano, Marco Gentile, Fulvia Terracciano, Francesco Perri. Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers. International Journal of Molecular Sciences 2024; 25(15): 8436 doi: 10.3390/ijms25158436
|
| 6 |
Octavio Caba, Carmelo Diéguez-Castillo, Joaquina Martínez-Galán, Irene González-Cebrián, Cristina Jiménez-Luna. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Oncology 2023; 15(2): 268-275 doi: 10.4251/wjgo.v15.i2.268
|
| 7 |
Immacolata Maietta, África González-Fernández, Rosana Simón-Vázquez. Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment. Advanced Drug Delivery Reviews 2025; 224: 115638 doi: 10.1016/j.addr.2025.115638
|
| 8 |
Aryan Salahi‐Niri, Paniz Zarand, Negar Mansouri, Parvaneh Rastgou, Omid Yazdani, Romina Esbati, Fatemeh Shojaeian, Behnaz Jahanbin, Zhaleh Mohsenifar, Hamid Asadzadeh Aghdaei, Farid Azmoudeh Ardalan, Seyed Amir Ahmad Safavi‐Naini. Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review. Health Science Reports 2025; 8(3) doi: 10.1002/hsr2.70412
|
| 9 |
James M. Lindberg, Giles F. Whalen, Jennifer LaFemina. The Pancreas. 2023; : 1037 doi: 10.1002/9781119876007.ch134
|
| 10 |
Ayumi Kashiro, Michimoto Kobayashi, Takanori Oh, Mitsuko Miyamoto, Jun Atsumi, Kengo Nagashima, Keiko Takeuchi, Satoshi Nara, Susumu Hijioka, Chigusa Morizane, Shojiro Kikuchi, Shingo Kato, Ken Kato, Hiroki Ochiai, Daisuke Obata, Yuya Shizume, Hiroshi Konishi, Yumiko Nomura, Kotone Matsuyama, Cassie Xie, Christin Wong, Ying Huang, Giman Jung, Sudhir Srivastava, Hiromu Kutsumi, Kazufumi Honda. Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer. Journal of Gastroenterology 2024; 59(3): 263 doi: 10.1007/s00535-023-02072-w
|
| 11 |
Jie Yang, Chengming Wen, Hongkai Guo, Yahui Chai, Guodong Sun, Huijuan Cheng. Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01750-4
|
| 12 |
Jakub Wnuk, Joanna Katarzyna Strzelczyk, Iwona Gisterek. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature. International Journal of Molecular Sciences 2023; 24(6): 5113 doi: 10.3390/ijms24065113
|
| 13 |
V. L. Ostanko, T. P. Kalacheva, K. A. Kulumaeva, N. A. Li, E. V. Beloborodova, I. L. Purlik, E. V. Kalyuzhina, N. G. Brazovskaya, V. V. Kalyuzhin. Markers of gastrointestinal diseases. Bulletin of Siberian Medicine 2025; 23(4): 177 doi: 10.20538/1682-0363-2024-4-177-186
|
| 14 |
Jan Bures, Darina Kohoutova, Jan Skrha, Bohus Bunganic, Ondrej Ngo, Stepan Suchanek, Pavel Skrha, Miroslav Zavoral. Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. Cancers 2023; 15(14): 3669 doi: 10.3390/cancers15143669
|
| 15 |
Mitchell S. Cappell, Martin Tobi. Pathogenic Variant Intraductal Papillary Mucinous Neoplasms Tumors Show Increased Tumor Growth Compared With Those With Familial Pancreatic Cancer Kindreds: Prognostic Indicators. Clinical Gastroenterology and Hepatology 2024; 22(9): 1962 doi: 10.1016/j.cgh.2024.01.031
|
| 16 |
Iman Mohammad Said Jallod, Ammar Khalo Abbas, Faheemah Ismael Yaqoob, Abdul-Aziz Ahmed Aziz. Bridging diabetes and cancer: harnessing biomarkers as dual sentinels for diagnosis, prognosis, and therapeutic advancements. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04209-5
|
| 17 |
Matthew R Kudelka, Wei Gu, Yasuyuki Matsumoto, Tongzhong Ju, Richard H Barnes II, Robert J Kardish, Jamie Heimburg-Molinaro, Sylvain Lehoux, Junwei Zeng, Cynthia Cohen, Brian S Robinson, Kinjal S Shah, Elliot L Chaikof, Sean R Stowell, Richard D Cummings. Targeting altered glycosylation in secreted tumor glycoproteins for broad cancer detection. Glycobiology 2023; 33(7): 567 doi: 10.1093/glycob/cwad035
|
| 18 |
Harshit Bhalla, Pravir Kumar. Advances in Digital Health and Medical Bioengineering. IFMBE Proceedings 2024; 109: 377 doi: 10.1007/978-3-031-62502-2_44
|
| 19 |
Raffaella M. Pozzi Mucelli, Miroslav Vujasinovic, Ana Farah-Mwais, Peter Gustavsson, Carlos Fernández Moro, Poya Ghorbani, Johannes-Matthias Löhr, Nikolaos Kartalis. Performance of MRI-based surveillance for high-risk individuals for pancreatic cancer. European Journal of Radiology 2025; 191: 112275 doi: 10.1016/j.ejrad.2025.112275
|
| 20 |
Weikang Kong, Lingxia Zhu, Tian Li, Jiao Chen, Bo Fan, Wenjing Ji, Chunli Zhang, Xueting Cai, Chunping Hu, Xiaoyan Sun, Peng Cao. Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancer. European Journal of Pharmacology 2023; 948: 175703 doi: 10.1016/j.ejphar.2023.175703
|
| 21 |
Emmanuel Kwaku Ofori, Nathaniel Ebo Aidoo. Diagnostic Landscape in Cancer Research. 2025; : 35 doi: 10.1016/B978-0-443-33849-6.00006-4
|
| 22 |
Yue Ma, Shiyun Chen, Guanghai Dai. Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy. Human Vaccines & Immunotherapeutics 2024; 20(1) doi: 10.1080/21645515.2024.2376429
|
| 23 |
Mahrou Vahabi, Annalisa Comandatore, Chiara Centra, Giovanni Blandino, Luca Morelli, Elisa Giovannetti. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer. Seminars in Cancer Biology 2023; 97: 50 doi: 10.1016/j.semcancer.2023.11.003
|
| 24 |
Mustafa Aydemir, Ali İhsan Kömür, Emine Selda Gündüz, Ceren Karaman, Onur Karaman. Breaking the Silence: AI-Enhanced Multi-Omics biosensors for liquid Biopsy-Based early diagnosis of pancreatic cancer. Microchemical Journal 2025; 215: 114118 doi: 10.1016/j.microc.2025.114118
|
| 25 |
Jessica L. Chitty, Thomas R. Cox. The extracellular matrix in cancer: from understanding to targeting. Trends in Cancer 2025; doi: 10.1016/j.trecan.2025.05.003
|
| 26 |
Ming Yang, Chun-Ye Zhang. Diagnostic biomarkers for pancreatic cancer: An update. World Journal of Gastroenterology 2021; 27(45): 7862-7865 doi: 10.3748/wjg.v27.i45.7862
|
| 27 |
Michael Goggins. The role of biomarkers in the early detection of pancreatic cancer. Familial Cancer 2024; 23(3): 309 doi: 10.1007/s10689-024-00381-4
|
| 28 |
Bin Wu, Guangming Zhang, Xiashuang Zhao, Jie Wang, Da Wang, Yipeng Zhang, Miao Yu, Hui Cai. Association between D-dimer levels and clinicopathological characteristics of pancreatic cancer and its role in prognosis: A systematic review and meta-analysis. Asian Journal of Surgery 2024; 47(8): 3417 doi: 10.1016/j.asjsur.2024.02.043
|
| 29 |
Takahiko Sakaue, Hironori Koga, Hideki Iwamoto, Toru Nakamura, Atsutaka Masuda, Toshimitsu Tanaka, Hiroyuki Suzuki, Hideya Suga, Shingo Hirai, Toru Hisaka, Yoshiki Naito, Keisuke Ohta, Kei-ichiro Nakamura, Karuppaiyah Selvendiran, Yoshinobu Okabe, Takuji Torimura, Takumi Kawaguchi. Pancreatic Juice-Derived microRNA-4516 and microRNA-4674 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma. Gastro Hep Advances 2024; 3(6): 761 doi: 10.1016/j.gastha.2024.04.011
|
| 30 |
M. S. Kniazeva, T. M. Shestopalova, L. M. Zabegina, A. V. Shalaev, A. K. Ratnikova, V. A. Kashchenko, S. L. Vorobyev, A. V. Malek. Prospects of differential diagnosis of focal lesion of pancreas by the microRNA assessment. South Russian Journal of Cancer 2023; 4(3): 20 doi: 10.37748/2686-9039-2023-4-3-3
|
| 31 |
Nicholas Aderinto, Muili O. Abdulbasit, Deji Olatunji, Mariam Edun. Unveiling the potential of galectin-3 as a diagnostic biomarker for pancreatic cancer: a review. Annals of Medicine & Surgery 2023; 85(11): 5557 doi: 10.1097/MS9.0000000000001363
|
| 32 |
Eman AE Badr, Waheed M. Salem, Yostena Mekhail, Hager Mohamed Rashed. The role of visfatin and omentin-1 gene polymorphism in pancreatic ductal adenocarcinoma (PDAC). Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10747-1
|
| 33 |
Madison Cox, Dominic Vitello, Akhil Chawla. Translating the multifaceted use of liquid biopsy to management of early disease in pancreatic adenocarcinoma. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1520717
|
| 34 |
Akash Bararia, Amlan Das, Sangeeta Mitra, Sudeep Banerjee, Aniruddha Chatterjee, Nilabja Sikdar. Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. World Journal of Gastrointestinal Oncology 2023; 15(9): 1505-1519 doi: 10.4251/wjgo.v15.i9.1505
Abstract(799) |
Core Tip(804) |
Full Article(HTML)(3888)
|
Full Article with Cover (PDF)-2302K(201)
|
Full Article (Word)-641K(63)
|
Audio-449K(3)
|
Peer-Review Report-207K(120)
|
Answering Reviewers-146K(119)
|
Full Article (PDF)-2009K(214)
|
Full Article (XML)-278K(118)
|
Times Cited (3)
|
Total Visits (9635)
|
Open
|
| 35 |
Alexander C. Schulick, Hunter B. Moore, Salvador Rodriguez Franco, Jessie G. Jiang, Barish H. Edil, Richard D. Schulick, Trevor L. Nydam, Martin D. McCarter, Marco Del Chiaro, Ana Gleisner. Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampullary and pancreatic adenocarcinoma. The American Journal of Surgery 2024; 238: 115820 doi: 10.1016/j.amjsurg.2024.115820
|
| 36 |
Luca Digiacomo, Damiano Caputo, Roberto Cammarata, Vincenzo La Vaccara, Roberto Coppola, Erica Quagliarini, Manuela Iacobini, Serena Renzi, Francesca Giulimondi, Daniela Pozzi, Giulio Caracciolo, Heinz Amenitsch. Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. Nanoscale 2025; 17(12): 7066 doi: 10.1039/D4NR02435D
|
| 37 |
Seema Kumari, Sujatha Peela, Mundla Srilatha, Bala Prabhakar Girish, Ganji Purnachandra Nagaraju. Adiponectin: its role in diabetic and pancreatic cancer. Molecular Aspects of Medicine 2025; 103: 101370 doi: 10.1016/j.mam.2025.101370
|
| 38 |
Marta Moretti, Antonella Farina, Antonio Angeloni, Emanuela Anastasi. Emerging horizons on molecular and circulating biomarkers in pancreatic adenocarcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1483306
|
| 39 |
Maja Mejza, Anna Bajer, Sora Wanibuchi, Ewa Małecka-Wojciesko. Can AI Be Useful in the Early Detection of Pancreatic Cancer in Patients with New-Onset Diabetes?. Biomedicines 2025; 13(4): 836 doi: 10.3390/biomedicines13040836
|
| 40 |
Hiroki Oyama, Tsuyoshi Hamada, Yousuke Nakai, Mariko Tanaka, Go Endo, Ryunosuke Hakuta, Kota Ishida, Kazunaga Ishigaki, Sachiko Kanai, Kohei Kurihara, Tomotaka Saito, Tatsuya Sato, Tatsunori Suzuki, Yukari Suzuki, Shinya Takaoka, Shuichi Tange, Yurie Tokito, Naminatsu Takahara, Tetsuo Ushiku, Mitsuhiro Fujishiro. Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases. Journal of Gastroenterology 2023; 58(10): 1068 doi: 10.1007/s00535-023-02028-0
|
| 41 |
Muhammad Begawan Bestari, Ignatius Ronaldi Joewono, Ari Fahrial Syam. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present. Biomolecules 2024; 14(3): 364 doi: 10.3390/biom14030364
|
| 42 |
Emmanuel Kwaku Ofori, Nathaniel Ebo Aidoo. Biomarker Landscape in Cancer Research. 2025; : 25 doi: 10.1016/B978-0-443-33902-8.00002-X
|
| 43 |
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Puolakkainen, Sakari Knuutila. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. Biomolecules 2022; 12(5): 652 doi: 10.3390/biom12050652
|
| 44 |
Bárbara Morão, Lídia Roque Ramos, Maria Helena Oliveira, Luísa Glória. Malignancy and mass-forming phenotypes of IgG4-related disease: a challenging diagnosis. BMJ Case Reports 2024; 17(7): e257372 doi: 10.1136/bcr-2023-257372
|
| 45 |
Gehan Hammad, Samah Mamdouh, Dina Mohamed Seoudi, Mohamed Ismail Seleem, Gehan Safwat, Rania Hassan Mohamed. Elevated expression patterns of P-element Induced Wimpy Testis (PIWI) transcripts are potential candidate markers for Hepatocellular Carcinoma. Cancer Biomarkers 2024; 39(2): 95 doi: 10.3233/CBM-230134
|
| 46 |
Markus Casper, Claus Mai, Manfred Lutz. DGIM Innere Medizin. Springer Reference Medizin 2024; : 1 doi: 10.1007/978-3-642-54676-1_123-3
|
| 47 |
Saima Firdaus, Rafat Parveen. mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer. IECGE 2024 2025; : 2 doi: 10.3390/blsf2025043002
|
| 48 |
Jolitta S. J. Britto, Xinwei Guan, Thi Kim Anh Tran, Zhihao Lei, Rohan Bahadur, Vaishwik Patel, Xiangwei Zhang, Sharon L. Wong, Ajayan Vinu. Emerging Multifunctional Carbon‐Nanomaterial‐Based Biosensors for Cancer Diagnosis. Small Science 2024; 4(3) doi: 10.1002/smsc.202300221
|
| 49 |
Laura Vilà-Quintana, Esther Fort, Laura Pardo, Maria T. Albiol-Quer, Maria Rosa Ortiz, Montserrat Capdevila, Anna Feliu, Anna Bahí, Marc Llirós, Esther Aguilar, Adelaida García-Velasco, Mireia M. Ginestà, Berta Laquente, Débora Pozas, Aleix Lluansí, Ville Nikolai Pimenoff, Victor Moreno, Libadro Jesús Garcia-Gil, Eric J. Duell, Robert Carreras-Torres, Xavier Aldeguer. Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study. Journal of Clinical Medicine 2024; 13(8): 2247 doi: 10.3390/jcm13082247
|
| 50 |
Lakshmi Sai Niharika Janga, Hembashima G Sambe, Mohamed Yasir, Ruzhual K Man, Amaresh Gogikar, Ankita Nanda, Lubna Mohammed. Holistic Understanding of the Role of Carbohydrate Antigen 19-9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.44382
|
| 51 |
Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, Francesco Novelli, Claudia Curcio. Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?. Cells 2024; 13(18): 1558 doi: 10.3390/cells13181558
|
| 52 |
Liang Zhang, Jiuling Zhang, Xue Zhang, Shuang Liu, Chunyu Qi, Shengyu Gao. miR‑100: A key tumor suppressor regulatory factor in human malignant tumors (Review). International Journal of Molecular Medicine 2025; 55(4): 1 doi: 10.3892/ijmm.2025.5508
|
| 53 |
Mohd Haris Jamal, Pratyush Porel, Khadga Raj Aran. Emerging biomarkers for pancreatic cancer: from early detection to personalized therapy. Clinical and Translational Oncology 2025; doi: 10.1007/s12094-025-03947-5
|
| 54 |
Xinxia Zhu, Brennan Olson, Dove Keith, Mason A Norgard, Peter R Levasseur, Parham Diba, Sara Protzek, Ju Li, Xiaolin Li, Tetiana Korzun, Ariana L Sattler, Abigail C Buenafe, Aaron J Grossberg, Daniel L Marks. GDF15 and LCN2 for early detection and prognosis of pancreatic cancer. Translational Oncology 2024; 50: 102129 doi: 10.1016/j.tranon.2024.102129
|
| 55 |
Dimitrios Stefanoudakis, Maximos Frountzas, Nikolaos V. Michalopoulos, Dimitrios Schizas, Dimitrios Theodorou, Konstantinos G. Toutouzas. Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications. Current Issues in Molecular Biology 2025; 47(5): 347 doi: 10.3390/cimb47050347
|
| 56 |
Lissuly Guadalupe Álvarez-Hilario, Eric Genaro Salmerón-Bárcenas, Pedro Antonio Ávila-López, Georgina Hernández-Montes, Elena Aréchaga-Ocampo, Roberto Herrera-Goepfert, Jorge Albores-Saavedra, María del Carmen Manzano-Robleda, Héctor Iván Saldívar-Cerón, Sandra Paola Martínez-Frías, María Del Rocío Thompson-Bonilla, Miguel Vargas, Rosaura Hernández-Rivas. Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico. International Journal of Molecular Sciences 2023; 24(20): 15193 doi: 10.3390/ijms242015193
|
| 57 |
Ziyi Xiang, Qihui Xie, Zili Yu. Exosomal DNA: Role in Reflecting Tumor Genetic Heterogeneity, Diagnosis, and Disease Monitoring. Cancers 2023; 16(1): 57 doi: 10.3390/cancers16010057
|
| 58 |
Jianye Chen, Benqi Fu, Zhongyi Xiang, Xindong Chen, Lu Wang, Yuan Qin, Xueqin Zhao, Xiumei Zhou, Pengfei Liu, Biao Huang. Sensitive amplified luminescent proximity homogeneous assay for the quantitative detection of CA242. Journal of Immunological Methods 2023; 517: 113487 doi: 10.1016/j.jim.2023.113487
|
| 59 |
Sanjana Naveen Prasad, Vipul Bansal, Rajesh Ramanathan. Non-invasive nanozyme sensors for urinalysis. TrAC Trends in Analytical Chemistry 2025; 183: 118100 doi: 10.1016/j.trac.2024.118100
|
| 60 |
L. Tharrun Daniel Paul, Ganesh Munuswamy-Ramanujam, Rajappan Chandra Satish Kumar, Vasukidevi Ramachandran, Dhanavathy Gnanasampanthapandian, Kanagaraj Palaniyandi. Biomarkers in Cancer Detection and Monitoring of Therapeutics. 2024; : 121 doi: 10.1016/B978-0-323-95114-2.00025-X
|
| 61 |
Pratik Singh, Mansi Patel, Doulat Bhowmik, Neha Kumari, Suresh Prajapati, Reeshu Gupta. Identification of common biomarkers affecting patient survival in cancers. World Academy of Sciences Journal 2024; 6(6) doi: 10.3892/wasj.2024.268
|
| 62 |
Mithum Senaratne, Shivling S Swami, Soe Lwin Aye, Yash Trivedi, Zoryana Bolgarina, Heet N Desai, Lubna Mohammed. Clinical Value of Circulating microRNAs in Diagnosis and Prognosis of Pancreatic Cancer: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.43931
|
| 63 |
Ye Tian, Tao Di, Chao Bai, Xinxi Li, Jun Luo, Zhenwei Yang, Lei Zhang, Wenbin Zhang. Triple cycling integrating with primer exchange reaction (TCiPER) for ultra-sensitive and label-free detection of MicroRNA. Microchemical Journal 2024; 197: 109782 doi: 10.1016/j.microc.2023.109782
|
| 64 |
Natalia Pawelec, Łukasz Durko, Ewa Małecka-Wojciesko. Changes Connected to Early Chronic Pancreatitis and Early Pancreatic Cancer in Endoscopic Ultrasonography (EUS): Clinical Implications. Cancers 2025; 17(11): 1891 doi: 10.3390/cancers17111891
|
| 65 |
Umbhorn Ungkulpasvich, Hideyuki Hatakeyama, Takaaki Hirotsu, Eric di Luccio. Pancreatic Cancer and Detection Methods. Biomedicines 2023; 11(9): 2557 doi: 10.3390/biomedicines11092557
|
| 66 |
Kaixin Hu, Chenyang Bian, Jiayin Yu, Dawei Jiang, Zhangjun Chen, Fengqing Zhao, Huangbao Li. Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03469-4
|
| 67 |
Nathália Faro de Brito, Luis Felipe Ribeiro Pinto, Matias Eliseo Melendez. Biosensors for liquid biopsy of pancreatic cancer. Microchemical Journal 2024; 196: 109679 doi: 10.1016/j.microc.2023.109679
|
| 68 |
Yaling Liang, Wei Chen, Yun Tang, Meijuan Chen. Identification of the Genetic Association Between Type-2-Diabetes and Pancreatic Cancer. Biochemical Genetics 2023; 61(3): 1143 doi: 10.1007/s10528-022-10308-2
|
| 69 |
Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, Infancia Lawrence, Arunkumar Radhakrishnan. Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer. Archives of Microbiology 2024; 206(4) doi: 10.1007/s00203-024-03914-8
|
| 70 |
Kim-Lea Reese, Klaus Pantel, Daniel J. Smit. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03166-w
|
| 71 |
Xuyao Liu, Qi Shi, Peng Qi, Ziming Wang, Tongyue Zhang, Sijia Zhang, Jiayan Wu, Zhaopei Guo, Jie Chen, Qiang Zhang. Recent advances in living cell nucleic acid probes based on nanomaterials for early cancer diagnosis. Asian Journal of Pharmaceutical Sciences 2024; 19(3): 100910 doi: 10.1016/j.ajps.2024.100910
|
| 72 |
Sara Pączek, Monika Zajkowska, Barbara Mroczko. Pigment Epithelial-Derived Factor in Pancreatic and Liver Cancers—From Inflammation to Cancer. Biomedicines 2024; 12(10): 2260 doi: 10.3390/biomedicines12102260
|
| 73 |
Helena J Janse van Rensburg, Pavlina Spiliopoulou, Lillian L Siu. Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents. The Oncologist 2022; 27(5): 352 doi: 10.1093/oncolo/oyac047
|
| 74 |
Jakub Wnuk, Dorota Hudy, Joanna Katarzyna Strzelczyk, Łukasz Michalecki, Kamil Dybek, Iwona Gisterek-Grocholska. Serum hsa-miR-22-3p, hsa-miR-885-5p, Lipase-to-Amylase Ratio, C-Reactive Protein, CA19-9, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Advanced Pancreatic Ductal Adenocarcinoma. Current Issues in Molecular Biology 2025; 47(1): 27 doi: 10.3390/cimb47010027
|